梦想家:通过基于网络的分析,探索药物不良反应和疾病表型的常见机制
bioRxiv : the preprint server for biology
|August 2, 2024
概括
DREAMER是一种新的网络方法,可以识别药物不良反应 (ADR) 和疾病表型的分子机制. 它有助于理解药物安全性,并通过分析蛋白质相互作用来重新定位药物.
科学领域:
- 药物基因组学 药物基因组学
- 系统生物学 系统生物学
- 计算生物学 计算生物学
背景情况:
- 药物不良反应 (ADR) 对患者安全和药物开发构成重大风险.
- 了解ADR的分子机制对于改善临床结果至关重要.
研究的目的:
- 介绍DREAMER,一种新的基于网络的方法来探索ADR机制.
- 确定ADR和疾病表型背后的分子途径和因果关系.
- 展示DREAMER在药物重新利用中的实用性.
主要方法:
- 从各种数据集中利用了一个全面的知识图表.
- 分析了蛋白质-蛋白质相互作用网络,以确定具有相似表型的药物/疾病之间的共同点.
- 应用基于网络的分析来识别与ADR机制相关的蛋白质集.
主要成果:
- 鉴定了与649个ADR中67个的作用机制相关的蛋白质.
- 突出了GABAergic信号在人格障碍和内出血中的凝血通路中的作用.
- 成功提出索塔洛尔,罗纳拉和迪尔蒂亚泽姆用于心脏骤停的重定位.
结论:
- 梦想者有效地检测出表型的基础分子机制.
- 该方法提供了对ADR因果关系的见解,并促进了药物重定向策略.
- 基于网络的方法对于剖析复杂的药物诱导的表型是有价值的.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
07:11Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
Published on: November 10, 2023
2.3K
相关概念视频
Pharmacovigilance
805
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
805
Analysis of Population Pharmacokinetic Data
244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244
Structure-Activity Relationships and Drug Design
689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Genome-wide Association Studies-GWAS
13.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.3K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K
Drug Discovery: Overview
7.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.7K
